Alzheimer’s Current Studies

Currently Enrolling Studies

If you or somebody you love is forgetful, has difficulty planning and solving problems, or gets lost in familiar places, it could be a sign of early Alzheimer's disease.

Check out our current enrolling studies below if you are interested in learning more about clinical trials aimed at slowing the progression of Alzheimer's disease. Call us today for more information.

Flyer: Seeking participants for an early Alzheimer's disease clinical trial; features a group of seniors in a variety of settings.

Merck Study

Do you or someone you know have mild cognitive impairment or mild dementia due to Alzheimer’s disease?

Learn about a clinical trial for early Alzheimer’s disease.

Who can join this clinical trial?

There are eligibility criteria that will determine if you qualify to participate. You may be able to join this clinical trial if you:

Are 50-85 years of age
Have mild cognitive impairment or mild dementia due to Alzheimer’s disease
Have a person (trial partner) who can go with you to specific trial visits

Other criteria will apply.

Learn more by contacting us today.

About the TRAVELLER study

The TRAVELLER study is designed to see if you might be a good fit for Roche clinical studies testing treatments to delay or prevent Alzheimer’s disease.

Help find ways that may be used to detect Alzheimer’s disease at an earlier stage.

Can I participate in this study?

You may be able to participate in the TRAVELLER study if you are:

50-90* years of age and willing to participate in a clinical study.
*Additional age restrictions may apply.

Learn more by calling today.

Alzheimer’s treatment awareness poster with pink background, smiling couple, and trial participation details

Help us make a difference in Alzheimer’s disease

research by joining the PrevenTRON study.

Alzheimer’s disease can begin years before symptoms appear. If you are between the ages of 55 and 80, you may be able to join a clinical study exploring a potential treatment that may help prevent and slow down Alzheimer’s disease.

To learn more about PrevenTRON or if you have any questions, please contact a member of the study team.